Study Evaluating PEG-G-CSF Injectionin Preventing Neutropenia After Chemotherapy

NCT06711523 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Neutropenia, Chemotherapy-Induced Febrile
Breast Neoplasm Female

Interventions

DRUG: PEG-G-CSF injection (Kexing Biopharmaceutical Co., Ltd.)
DRUG: PEG-G-CSF injection (Neulasta®，Amgen Europe B.V.)

Sponsor

Kexing Biopharm Co., Ltd.